Issue 31, 2025

A colorimetric probe based on peroxidase-like activity of CuAl-LDH/agarose nanocomposite hydrogel for determination of vancomycin in exhaled breath condensate

Abstract

Background: Vancomycin is a glycopeptide antibiotic used to treat certain bacterial infections. It works by interfering with RNA synthesis, altering cell membrane permeability, and inhibiting peptidoglycan synthesis in the cell wall. The recommended therapeutic concentration of vancomycin in plasma and serum is 5.0–40 μg mL−1, reflecting a narrow therapeutic window that can lead to toxic side effects and bacterial resistance if the concentration is too high or too low. Monitoring vancomycin in a low-cost and convenient way is significant in administering accurate dosages of vancomycin to prevent the development of bacterial resistance. Results: Herein, a colorimetric nanoprobe was established to detect vancomycin in exhaled breath condensate samples. This platform incorporated agarose hydrogels with nanozymes to initiate specific reactions and produce colorimetric signals. CuAl-layered double hydroxide was used as nanozyme, which exhibits peroxidase-like activity accelerating the oxidation of the colorless compound 3,3′,5,5′-tetramethylbenzidine (TMB) to the blue product oxTMB in the presence of hydrogen peroxide. The detection mechanism of vancomycin was its interaction with Cu in CuAl-LDH/agarose, inhibiting the oxidation process of TMB. The inhibiting effect of vancomycin led to a significant decrease in the analytical response across a concentration range of 0.04–0.3 μg mL−1. The inter- and intra-day relative standard deviations of the nanoprobe were recorded at 1.2% and 4.4%, respectively. This proposed system was effectively employed to quantify vancomycin levels in patients receiving the medication, with samples collected from the expiratory circuit of a mechanical ventilator. Significant: As a result, LDH/agarose nanocomposite catalyzed H2O2 : TMB system's benefits of simplicity, versatility, and cost-effectiveness make this platform a promising tool for colorimetric detection of vancomycin in clinical settings. Notably, this sensing platform can be customized for optical assays targeting different molecules by altering the encapsulated substances within the hydrogel.

Graphical abstract: A colorimetric probe based on peroxidase-like activity of CuAl-LDH/agarose nanocomposite hydrogel for determination of vancomycin in exhaled breath condensate

Article information

Article type
Paper
Submitted
19 May 2025
Accepted
08 Jul 2025
First published
17 Jul 2025
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2025,15, 25404-25412

A colorimetric probe based on peroxidase-like activity of CuAl-LDH/agarose nanocomposite hydrogel for determination of vancomycin in exhaled breath condensate

Z. Karimzadeh, A. Keyvani, V. Jouyban-Gharamaleki, M. Khoubnasabjafari and E. Rahimpour, RSC Adv., 2025, 15, 25404 DOI: 10.1039/D5RA03521J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements